Is Digital Pathology a Game-Changer for Histology in NASH Drug Development?
Thursday June 16, 2022 | 11:30 AM PDT | 02:30 PM EDT
Z. Reno Vlahcevic Professor of Medicine at Virginia Commonwealth University School of Medicine
Professor of Medicine, Director of Hepatology, at University of California at San Diego and Founding Director of the UCSD NAFLD Research Center
President & CEO, ProSciento, Inc. and Editor-in-Chief, Endocrinology, Diabetes & Metabolism
This event will be recorded and available for viewing approximately one week after the live event.
NASH Roundtable™ is a forum of leading hepatologists, endocrinologists and clinical development experts stewarding advances in science, clinical research and therapeutics for nonalcoholic fatty liver disease and steatohepatitis.
For questions or additional information please contact nashroundtable@prosciento.com or visit nashroundtable.com
The NASH Roundtable™ was established in 2018 as a platform to stimulate collaboration and build consensus towards validated biomarkers and endpoints and to support the development of effective and safe treatments. Today the Roundtable consists of distinguished physicians, researchers, and clinical development experts from three continents brought together by their common commitment to steward advances in science, clinical research, and therapeutics for fibrotic diseases.
